Croda International Plc

Croda International Plc

40.24
EUR
+0.16
(+0.40%)
4.38BMarket Cap
Feb 23Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.45
8.19
8.47
9.6
10.73
10.81
10.63
10.7
13.55
14.99
12.14
11.66
12.17
- -
Basic EPS, GAAP
1.39
1.29
1.41
1.52
1.85
1.86
1.73
1.55
2.3
4.66
1.23
1.14
0.44
- -
Free Cash Flow per Basic Share
1.14
0.86
0.89
1.22
0.81
1.23
1.49
1.28
1.36
1.12
1.06
0.99
1.19
- -
Dividend per Share
0.66
0.69
0.71
1.78
0.78
0.86
2.06
0.89
0.95
1.04
1.08
1.09
1.11
- -
Book Value per Share
3.22
3.76
4.55
4.68
6.4
7.7
6.68
11.36
12.56
17.31
16.85
16.35
15.69
15.69
Tangible Book Value per Share
1.35
1.85
1.99
1.91
3.39
4.16
3.22
1.96
3.44
8.33
6.76
6.96
6.48
6.48
Basic Weighted Avg Shares
128
128
128
130
128
128
130
130
139
139
140
140
140
139
Sales/Revenue/Turnover
1,077
1,047
1,082
1,244
1,373
1,387
1,378
1,390
1,890
2,089
1,695
1,628
1,699
- -
Operating Margin (%)
24.45
23.16
24.2
22.97
23.74
23.71
23.22
20.86
23.06
21.28
14.61
14.89
15.28
- -
Depreciation Expense
34
37
39
49
53
56
66
82
113
121
126
136
137
- -
Net Income, GAAP
178
165
181
197
237
239
224
202
321
649
171
159
62
- -
Effective Tax Rate (%)
28.87
27.99
28.22
28.33
24.64
25.02
25.97
25.19
21.56
16.24
27.17
23.2
28.9
- -
Profit Margin (%)
16.48
15.79
16.71
15.82
17.26
17.2
16.25
14.5
16.98
31.08
10.09
9.74
3.65
- -
Working Capital
175
195
222
237
253
300
231
354
434
673
589
548
451
451
LT Debt
213
202
308
415
426
448
512
847
873
481
660
651
534
534
Total Equity
419
489
607
609
830
998
869
1,595
1,766
2,431
2,368
2,297
2,202
2,202
Return on Invested Capital (%)
28.08
24
21.17
19.47
20.4
17.17
15.3
10.59
13.88
12.77
5.84
5.73
2.65
- -
Return on Capital (%)
29.63
25.49
22.2
20.27
21.37
17.89
15.88
10.86
13.03
23.2
6.16
5.96
2.69
- -
Return on Common Equity (%)
47.01
36.99
33.42
32.81
33.36
26.34
24.21
16.49
19.23
31.16
7.17
6.84
2.77
- -

Capital Structure

GBP

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
48
164
163
LT Borrowings
580
509
470
LT Finance Leases
71
66
64
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
140
140
139
Market Capitalization
4,721
4,202
3,818

Working Capital

GBP

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
884
923
907
Cash, Cash Equivalents & STI
167
158
173
Accounts Receivable, Net
277
373
295
Inventories
368
392
371
Total Current Liabilities
337
446
457
Payables & Accruals
- -
- -
- -
ST Debt
48
164
163
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.62%
7.73%
-4.13%
Free Cash Flow
7.07%
1.09%
21.08%
Net Income, GAAP
3.36%
3.94%
-60.88%
Sales/Revenue/Turnover
5.47%
5.61%
4.38%
Total Cash Common Dividend
22.26%
6.09%
1.77%

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,695
2024
- -
- -
1,628
2025
- -
- -
1,699

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.23
2024
- -
- -
1.14
2025
- -
- -
0.44

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1.08
2024
- -
- -
1.09
2025
- -
- -
1.11

Company Description

CEO
Stephen Edwards Foots
Full Time Employees
5,954
Sector
Process industries
Industry
Chemicals: specialty
Address
Cowick Hall Goole YO United Kingdom DN14 9AA
IPO Date
Jun 10, 1964
Website
croda.com
Business
Croda International Plc is a global leader in specialty chemicals, innovating, manufacturing, and distributing high-performance ingredients across diverse markets in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates primarily through three strategic segments: Consumer Care, Life Sciences, and Industrial Specialties. Within its Consumer Care division, Croda develops specialized and active components for a wide array of personal care and beauty applications, including skincare, haircare, sun protection, color cosmetics, and oral hygiene products, as well as ingredients for home care, industrial and institutional cleaning, and fragrances. The Life Sciences segment focuses on critical solutions for the healthcare and agricultural sectors. For healthcare, it provides excipients and adjuvants essential for drug delivery, supporting the entire lifecycle of pharmaceuticals, including biologics and vaccine components. In agriculture, it delivers innovative crop protection and seed enhancement technologies that boost yields and promote sustainable farming practices, such as regenerative agriculture. The Industrial Specialties segment supports a range of niche industrial markets, supplying crucial formulation ingredients and sustainable solutions for applications such as coatings, polymers, textiles, fibers, and water treatment. Founded in 1925, Croda's heritage is rooted in turning renewable raw materials into innovative ingredients, a principle that continues to drive its strategic focus on sustainability and "Smart science to improve lives™." The company emphasizes offering bio-based, biodegradable ingredients with reduced carbon footprints, aiming to be Climate, Land, and People Positive by 2030. Headquartered in Snaith, England, United Kingdom, Croda maintains a global operational footprint with manufacturing sites and innovation centers designed to be close to its diverse customer base. The company's unique value proposition lies in its innovation, sustainability leadership, and its ability to provide mission-critical ingredients that deliver significant functionality at low inclusion levels in customer formulations.

Company News

  • Croda International (OTCMKTS:COIHY) Share Price Crosses Below Fifty Day Moving Average – What’s Next?

  • Financial Survey: Sociedad Quimica y Minera (NYSE:SQM) vs. Croda International (OTCMKTS:COIHY)

  • Croda International Plc (COIHY) Q2 2026 Earnings Call Transcript

  • Croda International H1 Earnings Call Highlights

  • Croda climbs as second-quarter growth accelerates

  • Croda International Plc (COIHY) Q1 2026 Sales/Trading Call Transcript

  • Analyzing FUCHS (OTCMKTS:FUPBY) and Croda International (OTCMKTS:COIHY)

  • Croda tops FTSE 100 after Morgan Stanley upgrade on inflation pricing power

  • Croda bucks FTSE 100 rout as Goldman Sachs performs rare double upgrade

  • Croda International (COIHY) Upgraded to Buy: Here's Why

  • Croda International Plc (COIHY) Q4 2025 Earnings Call Transcript

  • Croda impresses as turnaround shows further progress

  • Croda reports top-end profits and sets out new growth targets

  • Croda rallies 7.6% as leading turns bullish ahead of results

  • Orion (NYSE:OEC) vs. Croda International (OTCMKTS:COIHY) Head-To-Head Contrast

  • Contrasting Elementis (OTCMKTS:ELMTY) and Croda International (OTCMKTS:COIHY)

  • Sensient Technologies (NYSE:SXT) versus Croda International (OTCMKTS:COIHY) Head-To-Head Review

  • Croda International (OTCMKTS:COIHY) & Westaim (OTCMKTS:WEDXF) Head to Head Analysis

  • US bank downgrades Croda as margin recovery stalls

  • Toray Industries (OTCMKTS:TRYIY) and Croda International (OTCMKTS:COIHY) Critical Review